Original Research
Published on 11 Nov 2025
C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
- 413 views